Show simple item record

dc.contributor.authorElamurugan, Santhalingam
dc.description.abstractPancreatic cancer is a deadly disease and a relatively uncommon form of cancer. However, it is projected to be the second leading cause of cancer deaths in the US by 2040. The 5-year survival rate of pancreatic cancer patients is 10 percent. Currently, there are no effective screening methods available. Extracellular vesicles are nanoparticles secreted by all cells and play versatile roles in human health. EVs can be used as a non-invasive biomarker for pancreatic cancer screening since they can be isolated from bodily fluids. Currently, single molecule biomarkers have been proposed for pancreatic cancer screening. They lack sensitivity and specificity. We studied the ‘collective attribute’ of protein secondary structures of EVs from two cancer (MiaPaCa2 and PANC-1) and one healthy cell line (HPNE). Protein secondary structures of EVs were studied using circular dichroism spectroscopy. We found that cancerous EVs contain more beta sheet rich proteins than non-cancerous EVs.en_US
dc.publisherNorth Dakota State Universityen_US
dc.rightsNDSU policy 190.6.2en_US
dc.titleEVCD, Targeting Beta Sheet Richness of Tumor Derived Extracellular Vesicles for Pancreatic Cancer Screeningen_US
dc.typeMaster's Paperen_US
dc.date.accessioned2022-04-28T18:53:51Z
dc.date.available2022-04-28T18:53:51Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/10365/32325
dc.rights.urihttps://www.ndsu.edu/fileadmin/policy/190.pdfen_US
ndsu.degreeMaster of Science (MS)en_US
ndsu.collegeEngineeringen_US
ndsu.programBiomedical Engineeringen_US
ndsu.advisorSun, Dali
dc.identifier.doi10.48655/10365/32325


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record